Joanna Canham
5PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 30, 2025
Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML.Nigel Russell, Jad Othman, Oliver Cumming
|Aug 06, 2025
Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML.Jad Othman, Nicola Potter, Sylvie D Freeman
|May 01, 2024
Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML.Jad Othman, Nicola Potter, Adam Ivey
|Feb 16, 2024
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission.Jad Othman, Nicola Potter, Adam Ivey
|May 12, 2023
A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trial.Jad Othman, Charlotte Wilhelm-Benartzi, Richard Dillon
Pageof 1
Frequent Collaborators
5 joint publications
Jad Othman
5 joint publications
Sylvie D Freeman
4 joint publications
Nicola Potter
3 joint publications
Sean Johnson
2 joint publications
Richard Dillon
2 joint publications
Steven Knapper
2 joint publications
Michelle Kleeman
2 joint publications
Mike Dennis
2 joint publications
Hans Beier Ommen
1 joint publications
Julie Wych
